Exact Sciences(EXAS) ZACKS·2024-10-29 17:01Core Viewpoint - Exact Sciences (EXAS) has received an upgrade to a Zacks Rank 1 (Strong Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which have a strong correlation with near-term stock price movements [4][6]. - Rising earnings estimates for Exact Sciences suggest an improvement in the company's underlying business, likely leading to an increase in stock price [5][10]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7][9]. - Only the top 5% of Zacks-covered stocks receive a 'Strong Buy' rating, indicating superior earnings estimate revisions [9][10]. Recent Earnings Estimate Revisions - For the fiscal year ending December 2024, Exact Sciences is expected to earn -$0.95 per share, reflecting a 15.9% change from the previous year [8]. - Over the past three months, the Zacks Consensus Estimate for Exact Sciences has increased by 25.2%, indicating a positive trend in earnings expectations [8].